Glyphic Biotechnologies

United States

Glyphic Biotechnologies

Venture Winner 2021 2021 Winner 2021 Winner Science Start-ups (Falling Walls Venture)

Although decoding the human genome through the invention of DNA sequencing has ushered in a new era of biomedical sciences, this blueprint is not enough. We are defined by more than our genes: to understand the human body, we must understand the proteins that actually perform our day-to-day functions–and malfunctions. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolutions, advancing beyond the decades old technologies based on mass spectrometry and ELISAs. This platform will enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of human biology.

Content by this speaker

Explore more content of Falling Walls